Patrick J. McEnany, President and CEO at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 10,000 shares at $4.89 ($49K) on 2019-10-03, disclosed to the SEC on 2019-10-03.
Seasonal purchase ($49k) by President and CEO — this insider has traded CPRX in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2024-11-15 | $4.1M | — | Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |